Diabetic Macular Edema (DME) Recruiting Phase 3 Trials for Faricimab (DB15303)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04432831A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular EdemaTreatment